Table 52

Quantitative syntheses of HDL-c data for omega-3 fatty acid plus statin therapy compared with statin monotherapy

PopulationNumber of trials reporting outcomeNumber of participants in relevant intervention groupsPoint EstimateLower CIUpper CI
Difference in mean change from baseline
Participants requiring intensive lipid lowering therapy1751401.80−5.619.21
Participants with vascular diseases175
Difference in mean percentage change from baseline (%)
All trials107,178,18032975.313.167.45

Abbreviations: CI = 95% confidence interval, HDL-c = high density lipoprotein cholesterol

From: 3, Results

Cover of Comparative Effectiveness of Lipid-Modifying Agents
Comparative Effectiveness of Lipid-Modifying Agents [Internet].
Comparative Effectiveness Reviews, No. 16.
Sharma M, Ansari MT, Soares-Weiser K, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.